nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C19—urine—nephrolithiasis	0.0334	0.195	CbGeAlD
Efavirenz—CYP1A2—urine—nephrolithiasis	0.0272	0.16	CbGeAlD
Efavirenz—CYP2C9—urine—nephrolithiasis	0.0259	0.152	CbGeAlD
Efavirenz—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0246	0.0297	CcSEcCtD
Efavirenz—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0217	0.0262	CcSEcCtD
Efavirenz—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0205	0.0248	CcSEcCtD
Efavirenz—CYP3A4—urine—nephrolithiasis	0.0197	0.116	CbGeAlD
Efavirenz—CYP2D6—urine—nephrolithiasis	0.0194	0.114	CbGeAlD
Efavirenz—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0227	CcSEcCtD
Efavirenz—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0212	CcSEcCtD
Efavirenz—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0209	CcSEcCtD
Efavirenz—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0204	CcSEcCtD
Efavirenz—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.015	0.0181	CcSEcCtD
Efavirenz—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0166	CcSEcCtD
Efavirenz—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0156	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0154	CcSEcCtD
Efavirenz—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0154	CcSEcCtD
Efavirenz—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0153	CcSEcCtD
Efavirenz—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0143	CcSEcCtD
Efavirenz—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0143	CcSEcCtD
Efavirenz—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0138	CcSEcCtD
Efavirenz—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0137	CcSEcCtD
Efavirenz—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0136	CcSEcCtD
Efavirenz—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.011	0.0132	CcSEcCtD
Efavirenz—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0132	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0131	CcSEcCtD
Efavirenz—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0128	CcSEcCtD
Efavirenz—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0127	CcSEcCtD
Efavirenz—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0123	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0097	0.0117	CcSEcCtD
Efavirenz—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00952	0.0115	CcSEcCtD
Efavirenz—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00941	0.0113	CcSEcCtD
Efavirenz—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0113	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00922	0.0111	CcSEcCtD
Efavirenz—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00915	0.011	CcSEcCtD
Efavirenz—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00912	0.011	CcSEcCtD
Efavirenz—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00907	0.0109	CcSEcCtD
Efavirenz—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00892	0.0108	CcSEcCtD
Efavirenz—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0107	CcSEcCtD
Efavirenz—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00873	0.0105	CcSEcCtD
Efavirenz—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00837	0.0101	CcSEcCtD
Efavirenz—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00835	0.0101	CcSEcCtD
Efavirenz—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00831	0.01	CcSEcCtD
Efavirenz—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00823	0.00992	CcSEcCtD
Efavirenz—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00805	0.0097	CcSEcCtD
Efavirenz—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0079	0.00952	CcSEcCtD
Efavirenz—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00779	0.00939	CcSEcCtD
Efavirenz—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00775	0.00935	CcSEcCtD
Efavirenz—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00746	0.009	CcSEcCtD
Efavirenz—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0089	CcSEcCtD
Efavirenz—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00877	CcSEcCtD
Efavirenz—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00716	0.00864	CcSEcCtD
Efavirenz—Tension—Hydrochlorothiazide—nephrolithiasis	0.00713	0.0086	CcSEcCtD
Efavirenz—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00712	0.00858	CcSEcCtD
Efavirenz—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00706	0.00851	CcSEcCtD
Efavirenz—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00848	CcSEcCtD
Efavirenz—CYP2B6—nephron tubule—nephrolithiasis	0.00703	0.0412	CbGeAlD
Efavirenz—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00685	0.00826	CcSEcCtD
Efavirenz—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00681	0.00821	CcSEcCtD
Efavirenz—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00675	0.00813	CcSEcCtD
Efavirenz—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00672	0.0081	CcSEcCtD
Efavirenz—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00668	0.00806	CcSEcCtD
Efavirenz—CYP1A2—renal system—nephrolithiasis	0.00667	0.0391	CbGeAlD
Efavirenz—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00664	0.00801	CcSEcCtD
Efavirenz—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00791	CcSEcCtD
Efavirenz—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00653	0.00788	CcSEcCtD
Efavirenz—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00786	CcSEcCtD
Efavirenz—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00642	0.00775	CcSEcCtD
Efavirenz—CYP2B6—renal system—nephrolithiasis	0.00639	0.0374	CbGeAlD
Efavirenz—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00639	0.0077	CcSEcCtD
Efavirenz—Cough—Hydrochlorothiazide—nephrolithiasis	0.00634	0.00765	CcSEcCtD
Efavirenz—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00746	CcSEcCtD
Efavirenz—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00746	CcSEcCtD
Efavirenz—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00746	CcSEcCtD
Efavirenz—CYP2B6—kidney—nephrolithiasis	0.00618	0.0362	CbGeAlD
Efavirenz—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00744	CcSEcCtD
Efavirenz—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00612	0.00737	CcSEcCtD
Efavirenz—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00605	0.0073	CcSEcCtD
Efavirenz—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00721	CcSEcCtD
Efavirenz—Shock—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00704	CcSEcCtD
Efavirenz—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00701	CcSEcCtD
Efavirenz—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00698	CcSEcCtD
Efavirenz—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00692	CcSEcCtD
Efavirenz—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00682	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00652	CcSEcCtD
Efavirenz—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00647	CcSEcCtD
Efavirenz—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00642	CcSEcCtD
Efavirenz—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00529	0.00638	CcSEcCtD
Efavirenz—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00636	CcSEcCtD
Efavirenz—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00522	0.0063	CcSEcCtD
Efavirenz—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00622	CcSEcCtD
Efavirenz—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00617	CcSEcCtD
Efavirenz—Pain—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00612	CcSEcCtD
Efavirenz—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00612	CcSEcCtD
Efavirenz—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00489	0.0059	CcSEcCtD
Efavirenz—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00585	CcSEcCtD
Efavirenz—CYP3A4—renal system—nephrolithiasis	0.00483	0.0283	CbGeAlD
Efavirenz—CYP2D6—renal system—nephrolithiasis	0.00475	0.0278	CbGeAlD
Efavirenz—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00568	CcSEcCtD
Efavirenz—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00566	CcSEcCtD
Efavirenz—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00566	CcSEcCtD
Efavirenz—CYP3A4—kidney—nephrolithiasis	0.00466	0.0273	CbGeAlD
Efavirenz—CYP2D6—kidney—nephrolithiasis	0.00459	0.0269	CbGeAlD
Efavirenz—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00527	CcSEcCtD
Efavirenz—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00513	CcSEcCtD
Efavirenz—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00506	CcSEcCtD
Efavirenz—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00406	0.0049	CcSEcCtD
Efavirenz—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00473	CcSEcCtD
Efavirenz—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00455	CcSEcCtD
Efavirenz—Rash—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00451	CcSEcCtD
Efavirenz—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00451	CcSEcCtD
Efavirenz—Headache—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00448	CcSEcCtD
Efavirenz—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00425	CcSEcCtD
